Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
22.04.2024 - CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) - Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, today announced that six abstracts highlighting ...
Source: wallstreet-online.de
